Drugs for Urinary Incontinence and Overactive Bladder: Global Markets to 2022
Report Scope:
This research report categorizes the drugs for urinary incontinence and overactive bladder by type. Product type include Idiopathic Bladder Overactivity, and Neurogenic Bladder Overactivity.
Report Includes:
This research report categorizes the drugs for urinary incontinence and overactive bladder by type. Product type include Idiopathic Bladder Overactivity, and Neurogenic Bladder Overactivity.
Report Includes:
- 96 data tables.
- An overview of the global market for drugs for urinary incontinence and overactive bladder
- Analyses of global market trends, with data from 2013 to 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Coverage of types of urinary incontinence such as urge incontinence (UUI), stress incontinence (SUI), overflow incontinence (OUI), functional incontinence (FUI), and mixed symptoms (MUI)
- Identification of effective treatment options for incontinence and overactive bladder
- Analyses of Idiopathic bladder overactivity and neurogenic bladder overactivity and their probable causes
- Detailed profiles of key competitors of the market, including Astellas Pharma Inc., Pfizer, Inc., Allergan, PLC., Merck & Co., Mylan N.V., Teva Pharmaceutical Industries Limited and Ferring Pharmaceuticals A/S
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET CHARACTERISTICS
Types of Incontinence:
Causes of Incontinence and Overactive Bladder:
Treatment of Incontinence and Overactive Bladder
CHAPTER 4 DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET SIZE AND GROWTH
Historic Market Growth
Drivers of the Market
Restraints on the Market
Forecast Market Growth
Drivers of the Market
Restraints on the Market
CHAPTER 5 DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET TRENDS AND STRATEGIES
Drugs Developed for Alternative Delivery Systems
Drug Pipeline
New Class of Treatment for Overactive Bladders
CHAPTER 6 PESTLE ANALYSIS
Political
Economic
Social
Technological
Legal
Environmental
CHAPTER 7 DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET SEGMENTATION
Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment
Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment
Global Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast, by Segment, 2013-2022
Idiopathic Bladder Overactivity
Market Characteristics
Neurogenic Bladder Overactivity
Market Characteristics
CHAPTER 8 DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET: REGIONAL AND COUNTRY ANALYSES
Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Region
Global Drugs for Urinary Incontinence and Overactive Bladder Market, 2013-2022, Historic and Forecast, by Region
Global Drugs for Urinary Incontinence and Overactive Bladder Market Segmentation, by Region, 2017
Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Country
Global Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast, by Country
Global Drugs for Urinary Incontinence and Overactive Bladder Market Segmentation, 2017, by Country
CHAPTER 9 DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET CUSTOMER INFORMATION
Impact of Overactive Bladder (OAB) and Related Symptoms
Effect of Yoga on Urinary Incontinence
Lack of Awareness about Overactive Bladder
Pregnant Women at Higher Risk of Suffering from Urinary Incontinence
Treatment Vs. Placebo Effect
Inadequate Treatments for Overactive Bladder (OAB) Symptoms
CHAPTER 10 GLOBAL DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET COMPARISON WITH MACRO ECONOMIC FACTORS
Global Per Capita Average Drugs for Urinary Incontinence and Overactive Bladder Market Expenditure
CHAPTER 11 ASIA-PACIFIC DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET
Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Region Information
Market Information
Background Information
End User Industries Information
Government Initiatives
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market Forecast Market
Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment
Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast CAGR, by Segment
CHAPTER 12 ASIA-PACIFIC DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET: COUNTRY ANALYSIS
China Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Country Information
Market Information
Background Information
End User Industries Information
Government Initiatives
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
China Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
China Drugs for Urinary Incontinence and Overactive Bladder Market Forecast Market, 2017-2022
China Market Size, by Segment
China Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast, by Segment, 2013-2022
India Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Country Information
Market Information
Background Information
End User Industries Information
Government Initiatives
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
India Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
India Drugs for Urinary Incontinence and Overactive Bladder Market Forecast Market, 2017-2022
India Market Size, by Segment
India Drugs for Urinary Incontinence and Overactive Bladder Market, 2013-2022, Historic and Forecast, by Segment
Japan Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Country Information
Market Information
Background Information
End User Industries Information
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
Japan Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
Japan Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Japan Market Size, by Segment
Japan Drugs for Urinary Incontinence and Overactive Bladder Market, 2013-2022, Historic and Forecast, by Segment
Australia Drugs for Urinary Incontinence and Overactive Bladder Market
Australia Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
Australia Drugs for Urinary Incontinence and Overactive Bladder Market Forecast Market, 2017-2022
Australia Market Size, by Segment
Australia Drugs for Urinary Incontinence and Overactive Bladder Market, 2013-2022, Historic and Forecast, by Segment
CHAPTER 13 WESTERN EUROPE DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET
Western European Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Region Information
Market Information
Background Information
End User Industries Information
Government Initiatives
Investments Drugs for Urinary Incontinence and Overactive Bladder in Market
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
Western Europe Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
Western Europe Drugs for Urinary Incontinence and Overactive Bladder Market Forecast Market, 2017-2022
Western Europe Market Size, by Segment
Western Europe Drugs for Urinary Incontinence and Overactive Bladder Market, 2013-2022, Historic and Forecast, by Segment
CHAPTER 14 UK DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET: COUNTRY ANALYSIS
UK Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Country Information
Market Information
Background Information
End User Industries Information
Government Initiatives
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
UK Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
UK Drugs for Urinary Incontinence and Overactive Bladder Market Forecast Market, 2017-2022
UK Market Size, by Segment
UK Drugs for Urinary Incontinence and Overactive Bladder Market, 2013-2022, Historic and Forecast, by Segment
Germany Drugs for Urinary Incontinence and Overactive Bladder Market
Germany Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
Germany Drugs for Urinary Incontinence and Overactive Bladder Market Forecast Market, 2017-2022
Germany Market Size, by Segment
Germany Drugs for Urinary Incontinence and Overactive Bladder Market, 2013-2022, Historic and Forecast, by Segment
France Drugs for Urinary Incontinence and Overactive Bladder Market
France Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
France Drugs for Urinary Incontinence and Overactive Bladder Market Forecast Market, 2017-2022
France Market Size, by Segment
France Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast, by Segment, 2013-2022
Italy Drugs for Urinary Incontinence and Overactive Bladder Market
Italy Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
Italy Drugs for Urinary Incontinence and Overactive Bladder Market Forecast Market, 2017-2022
Italy Market Size, by Segment
Italy Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast, by Segment, 2013-2022
Spain Drugs for Urinary Incontinence and Overactive Bladder Market
Spain Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
Spain Drugs for Urinary Incontinence and Overactive Bladder Market Forecast Market, 2017-2022
Spain Market Size, by Segment
Spain Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast, by Segment, 2013-2022
CHAPTER 15 EASTERN EUROPE DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET
Eastern European Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Region Information
Market Information
Background Information
End User Industries Information
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
Eastern Europe Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Eastern Europe Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Eastern Europe Market Size, by Segment
Eastern Europe Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast, by Segment, 2013-2022
CHAPTER 16 EASTERN EUROPE DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET: COUNTRY ANALYSIS
Russia Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Russia Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Russia Market Size, by Segment
Russia Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast, by Segment, 2013-2022
CHAPTER 17 NORTH AMERICA DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET
North America Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Region Information
Market Information
Background Information
End User Industries Information
Investments in Drugs for Urinary Incontinence and Overactive Bladder Market
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
North America Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
North America Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
North America Market Size, by Segment
North America Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast, by Segment, 2013-2022
CHAPTER 18 NORTH AMERICA DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET: COUNTRY ANALYSIS
USA Drugs for Urinary Incontinence and Overactive Bladder Market
USA Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
USA Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
USA Market Size, by Segment
USA Drugs for Urinary Incontinence and Overactive Bladder Market, 2013-2022, Historic and Forecast, by Segment
CHAPTER 19 SOUTH AMERICA DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET
South America Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Region Information
Market Information
Background Information
End User Industries Information
Government Initiatives
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
South America Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
South America Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
South America Market Size, by Segment
South America Drugs for Urinary Incontinence and Overactive Bladder Historic and Forecast Market, by Segment, 2013-2022
CHAPTER 20 SOUTH AMERICA DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET: COUNTRY ANALYSIS
Brazil Drugs for Urinary Incontinence and Overactive Bladder Market
Brazil Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2016
Brazil Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Brazil Market Size, by Segment
Brazil Drugs for Urinary Incontinence and Overactive Bladder Historic and Forecast Market, by Segment, 2013-2022
CHAPTER 21 MIDDLE EAST DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET
Middle Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Region Information
Market Information
Background Information
End User Industries Information
Government Initiatives
Investments in Drugs for Urinary Incontinence and Overactive Bladder Market
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
Middle East Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Middle East Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Middle East Market Size, by Segment
Middle East Drugs for Urinary Incontinence and Overactive Bladder Historic and Forecast Market, by Segment, 2013-2022
CHAPTER 22 AFRICA DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET
Africa Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Region Information
Market Information
Background Information
End User Industries Information
Government Initiatives
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
Africa Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Africa Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Africa Market Size, by Segment
Africa Drugs for Urinary Incontinence and Overactive Bladder Historic and Forecast Market, by Segment, 2013-2022
CHAPTER 23 DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET: COMPETITIVE LANDSCAPE
Company Profiles
ALLERGAN PLC
ASTELLAS PHARMA INC.
MERCK & COMPANY, INC.
MYLAN N.V.
PFIZER
CHAPTER 24 KEY MERGERS AND ACQUISITIONS IN THE DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET
Actavis Acquired Allergan
Endo International Acquired Par Pharmaceuticals
Mylan Acquired Meda
CHAPTER 25 APPENDIX
NAICS Definitions of Industry Covered in This Report
Drugs for Urinary Incontinence and Overactive Bladder Market
Research Methodology
CHAPTER 26 REFERENCES
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET CHARACTERISTICS
Types of Incontinence:
Causes of Incontinence and Overactive Bladder:
Treatment of Incontinence and Overactive Bladder
CHAPTER 4 DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET SIZE AND GROWTH
Historic Market Growth
Drivers of the Market
Restraints on the Market
Forecast Market Growth
Drivers of the Market
Restraints on the Market
CHAPTER 5 DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET TRENDS AND STRATEGIES
Drugs Developed for Alternative Delivery Systems
Drug Pipeline
New Class of Treatment for Overactive Bladders
CHAPTER 6 PESTLE ANALYSIS
Political
Economic
Social
Technological
Legal
Environmental
CHAPTER 7 DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET SEGMENTATION
Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment
Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment
Global Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast, by Segment, 2013-2022
Idiopathic Bladder Overactivity
Market Characteristics
Neurogenic Bladder Overactivity
Market Characteristics
CHAPTER 8 DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET: REGIONAL AND COUNTRY ANALYSES
Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Region
Global Drugs for Urinary Incontinence and Overactive Bladder Market, 2013-2022, Historic and Forecast, by Region
Global Drugs for Urinary Incontinence and Overactive Bladder Market Segmentation, by Region, 2017
Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Country
Global Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast, by Country
Global Drugs for Urinary Incontinence and Overactive Bladder Market Segmentation, 2017, by Country
CHAPTER 9 DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET CUSTOMER INFORMATION
Impact of Overactive Bladder (OAB) and Related Symptoms
Effect of Yoga on Urinary Incontinence
Lack of Awareness about Overactive Bladder
Pregnant Women at Higher Risk of Suffering from Urinary Incontinence
Treatment Vs. Placebo Effect
Inadequate Treatments for Overactive Bladder (OAB) Symptoms
CHAPTER 10 GLOBAL DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET COMPARISON WITH MACRO ECONOMIC FACTORS
Global Per Capita Average Drugs for Urinary Incontinence and Overactive Bladder Market Expenditure
CHAPTER 11 ASIA-PACIFIC DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET
Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Region Information
Market Information
Background Information
End User Industries Information
Government Initiatives
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market Forecast Market
Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment
Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast CAGR, by Segment
CHAPTER 12 ASIA-PACIFIC DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET: COUNTRY ANALYSIS
China Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Country Information
Market Information
Background Information
End User Industries Information
Government Initiatives
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
China Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
China Drugs for Urinary Incontinence and Overactive Bladder Market Forecast Market, 2017-2022
China Market Size, by Segment
China Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast, by Segment, 2013-2022
India Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Country Information
Market Information
Background Information
End User Industries Information
Government Initiatives
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
India Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
India Drugs for Urinary Incontinence and Overactive Bladder Market Forecast Market, 2017-2022
India Market Size, by Segment
India Drugs for Urinary Incontinence and Overactive Bladder Market, 2013-2022, Historic and Forecast, by Segment
Japan Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Country Information
Market Information
Background Information
End User Industries Information
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
Japan Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
Japan Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Japan Market Size, by Segment
Japan Drugs for Urinary Incontinence and Overactive Bladder Market, 2013-2022, Historic and Forecast, by Segment
Australia Drugs for Urinary Incontinence and Overactive Bladder Market
Australia Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
Australia Drugs for Urinary Incontinence and Overactive Bladder Market Forecast Market, 2017-2022
Australia Market Size, by Segment
Australia Drugs for Urinary Incontinence and Overactive Bladder Market, 2013-2022, Historic and Forecast, by Segment
CHAPTER 13 WESTERN EUROPE DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET
Western European Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Region Information
Market Information
Background Information
End User Industries Information
Government Initiatives
Investments Drugs for Urinary Incontinence and Overactive Bladder in Market
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
Western Europe Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
Western Europe Drugs for Urinary Incontinence and Overactive Bladder Market Forecast Market, 2017-2022
Western Europe Market Size, by Segment
Western Europe Drugs for Urinary Incontinence and Overactive Bladder Market, 2013-2022, Historic and Forecast, by Segment
CHAPTER 14 UK DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET: COUNTRY ANALYSIS
UK Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Country Information
Market Information
Background Information
End User Industries Information
Government Initiatives
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
UK Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
UK Drugs for Urinary Incontinence and Overactive Bladder Market Forecast Market, 2017-2022
UK Market Size, by Segment
UK Drugs for Urinary Incontinence and Overactive Bladder Market, 2013-2022, Historic and Forecast, by Segment
Germany Drugs for Urinary Incontinence and Overactive Bladder Market
Germany Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
Germany Drugs for Urinary Incontinence and Overactive Bladder Market Forecast Market, 2017-2022
Germany Market Size, by Segment
Germany Drugs for Urinary Incontinence and Overactive Bladder Market, 2013-2022, Historic and Forecast, by Segment
France Drugs for Urinary Incontinence and Overactive Bladder Market
France Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
France Drugs for Urinary Incontinence and Overactive Bladder Market Forecast Market, 2017-2022
France Market Size, by Segment
France Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast, by Segment, 2013-2022
Italy Drugs for Urinary Incontinence and Overactive Bladder Market
Italy Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
Italy Drugs for Urinary Incontinence and Overactive Bladder Market Forecast Market, 2017-2022
Italy Market Size, by Segment
Italy Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast, by Segment, 2013-2022
Spain Drugs for Urinary Incontinence and Overactive Bladder Market
Spain Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, 2013-2017
Spain Drugs for Urinary Incontinence and Overactive Bladder Market Forecast Market, 2017-2022
Spain Market Size, by Segment
Spain Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast, by Segment, 2013-2022
CHAPTER 15 EASTERN EUROPE DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET
Eastern European Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Region Information
Market Information
Background Information
End User Industries Information
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
Eastern Europe Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Eastern Europe Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Eastern Europe Market Size, by Segment
Eastern Europe Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast, by Segment, 2013-2022
CHAPTER 16 EASTERN EUROPE DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET: COUNTRY ANALYSIS
Russia Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Russia Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Russia Market Size, by Segment
Russia Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast, by Segment, 2013-2022
CHAPTER 17 NORTH AMERICA DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET
North America Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Region Information
Market Information
Background Information
End User Industries Information
Investments in Drugs for Urinary Incontinence and Overactive Bladder Market
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
North America Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
North America Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
North America Market Size, by Segment
North America Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast, by Segment, 2013-2022
CHAPTER 18 NORTH AMERICA DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET: COUNTRY ANALYSIS
USA Drugs for Urinary Incontinence and Overactive Bladder Market
USA Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
USA Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
USA Market Size, by Segment
USA Drugs for Urinary Incontinence and Overactive Bladder Market, 2013-2022, Historic and Forecast, by Segment
CHAPTER 19 SOUTH AMERICA DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET
South America Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Region Information
Market Information
Background Information
End User Industries Information
Government Initiatives
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
South America Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
South America Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
South America Market Size, by Segment
South America Drugs for Urinary Incontinence and Overactive Bladder Historic and Forecast Market, by Segment, 2013-2022
CHAPTER 20 SOUTH AMERICA DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET: COUNTRY ANALYSIS
Brazil Drugs for Urinary Incontinence and Overactive Bladder Market
Brazil Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2016
Brazil Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Brazil Market Size, by Segment
Brazil Drugs for Urinary Incontinence and Overactive Bladder Historic and Forecast Market, by Segment, 2013-2022
CHAPTER 21 MIDDLE EAST DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET
Middle Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Region Information
Market Information
Background Information
End User Industries Information
Government Initiatives
Investments in Drugs for Urinary Incontinence and Overactive Bladder Market
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
Middle East Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Middle East Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Middle East Market Size, by Segment
Middle East Drugs for Urinary Incontinence and Overactive Bladder Historic and Forecast Market, by Segment, 2013-2022
CHAPTER 22 AFRICA DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET
Africa Drugs for Urinary Incontinence and Overactive Bladder Market Overview
Region Information
Market Information
Background Information
End User Industries Information
Government Initiatives
Regulatory Bodies
Regulations
Taxes Levied
Corporate Tax Structure
Major Associations
Major Companies
Africa Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Africa Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Africa Market Size, by Segment
Africa Drugs for Urinary Incontinence and Overactive Bladder Historic and Forecast Market, by Segment, 2013-2022
CHAPTER 23 DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET: COMPETITIVE LANDSCAPE
Company Profiles
ALLERGAN PLC
ASTELLAS PHARMA INC.
MERCK & COMPANY, INC.
MYLAN N.V.
PFIZER
CHAPTER 24 KEY MERGERS AND ACQUISITIONS IN THE DRUGS FOR URINARY INCONTINENCE AND OVERACTIVE BLADDER MARKET
Actavis Acquired Allergan
Endo International Acquired Par Pharmaceuticals
Mylan Acquired Meda
CHAPTER 25 APPENDIX
NAICS Definitions of Industry Covered in This Report
Drugs for Urinary Incontinence and Overactive Bladder Market
Research Methodology
CHAPTER 26 REFERENCES
LIST OF TABLES
Summary Table: Global Drugs for Urinary Incontinence and Overactive Bladder Market, Through 2022
Table 1: Global Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 2: Global Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 3: Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 4: Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Generic and Branded, 2017
Table 5: Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 6: Global Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 7: Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Region, 2017
Table 8: Global Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Region, 2013-2022
Table 9: Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Region, 2017
Table 10: Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Country, 2017
Table 11: Global Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Country, 2013-2022
Table 12: Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Country, 2017
Table 13: Global Per Capita Average Drugs for Urinary Incontinence and Overactive Bladder Market Expenditure, 2013-2022
Table 14: Asia-Pacific-Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 15: Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 16: Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 17: Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 18: Chinese Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, Through 2017
Table 19: Chinese Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 20: Chinese Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 21: Chinese Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 22: Indian Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 23: Indian Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 24: Indian Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 25: Indian Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 26: Japanese Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 27: Japanese Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 28: Japanese Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 29: Japanese Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 30: Australian Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 31: Australian Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 32: Australian Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 33: Australian Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 34: Western European Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 35: Western European Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 36: Western European Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 37: Western European Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 38: UK Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 39: UK Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 40: UK Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 41: UK Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 42: Germany Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 43: Germany Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 44: Germany Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 45: Germany Drugs for Urinary Incontinence and Overactive Bladder Market Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 46: France Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 47: France Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 48: France Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 49: France Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 50: Italy Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 51: Italy Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 52: Italy Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 53: Italy Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 54: Spain Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 55: Spain Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 56: Spain Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 57: Spain Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 58: Eastern European Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 59: Eastern European Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 60: Eastern European Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 61: Eastern European Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 62: Russian Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 63: Russian Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 64: Russian Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 65: Russian Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 66: North American Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 67: North American Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 68: North American Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 69: North American Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 70: USA Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 71: USA Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 72: USA Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 73: USA Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 74: South American Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 75: South American Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 76: South American Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 77: South American Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 78: Brazil Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 79: Brazil Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 80: Brazil Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 81: Brazil Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 82: Middle East Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 83: Middle East Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 84: Middle East Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 85: Middle East Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 86: African Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 87: African Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 88: African Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 89: African Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 90: Global Market Shares for Key Competitors of Drugs for Urinary Incontinence and Overactive Bladder Market, 2017
Table 91: Allergan PLC: Financial Performance, 2013-2017
Table 92: Astellas Pharma Inc.: Financial Performance, 2013-2016
Table 93: Merck & Company, Inc.: Financial Performance, 2013-2016
Table 94: Mylan N.V.: Financial Performance, 2013-2017
Table 95: Pfizer Inc.: Financial Performance, 2013-2017
Table 96: Market Data Sources
Summary Table: Global Drugs for Urinary Incontinence and Overactive Bladder Market, Through 2022
Table 1: Global Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 2: Global Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 3: Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 4: Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Generic and Branded, 2017
Table 5: Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 6: Global Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 7: Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Region, 2017
Table 8: Global Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Region, 2013-2022
Table 9: Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Region, 2017
Table 10: Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Country, 2017
Table 11: Global Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Country, 2013-2022
Table 12: Global Drugs for Urinary Incontinence and Overactive Bladder Market, by Country, 2017
Table 13: Global Per Capita Average Drugs for Urinary Incontinence and Overactive Bladder Market Expenditure, 2013-2022
Table 14: Asia-Pacific-Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 15: Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 16: Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 17: Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 18: Chinese Drugs for Urinary Incontinence and Overactive Bladder Market Historic Market, Through 2017
Table 19: Chinese Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 20: Chinese Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 21: Chinese Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 22: Indian Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 23: Indian Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 24: Indian Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 25: Indian Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 26: Japanese Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 27: Japanese Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 28: Japanese Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 29: Japanese Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 30: Australian Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 31: Australian Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 32: Australian Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 33: Australian Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 34: Western European Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 35: Western European Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 36: Western European Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 37: Western European Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 38: UK Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 39: UK Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 40: UK Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 41: UK Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 42: Germany Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 43: Germany Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 44: Germany Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 45: Germany Drugs for Urinary Incontinence and Overactive Bladder Market Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 46: France Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 47: France Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 48: France Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 49: France Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 50: Italy Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 51: Italy Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 52: Italy Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 53: Italy Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 54: Spain Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 55: Spain Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 56: Spain Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 57: Spain Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 58: Eastern European Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 59: Eastern European Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 60: Eastern European Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 61: Eastern European Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 62: Russian Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 63: Russian Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 64: Russian Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 65: Russian Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 66: North American Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 67: North American Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 68: North American Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 69: North American Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 70: USA Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 71: USA Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 72: USA Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 73: USA Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 74: South American Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 75: South American Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 76: South American Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 77: South American Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 78: Brazil Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 79: Brazil Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 80: Brazil Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 81: Brazil Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 82: Middle East Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 83: Middle East Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 84: Middle East Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 85: Middle East Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 86: African Drugs for Urinary Incontinence and Overactive Bladder Historic Market, Through 2017
Table 87: African Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, Through 2022
Table 88: African Drugs for Urinary Incontinence and Overactive Bladder Market, by Segment, 2017
Table 89: African Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Table 90: Global Market Shares for Key Competitors of Drugs for Urinary Incontinence and Overactive Bladder Market, 2017
Table 91: Allergan PLC: Financial Performance, 2013-2017
Table 92: Astellas Pharma Inc.: Financial Performance, 2013-2016
Table 93: Merck & Company, Inc.: Financial Performance, 2013-2016
Table 94: Mylan N.V.: Financial Performance, 2013-2017
Table 95: Pfizer Inc.: Financial Performance, 2013-2017
Table 96: Market Data Sources
LIST OF FIGURES
Summary Figure: Global Drugs for Urinary Incontinence and Overactive Bladder Market, 2017-2022
Figure 1: Global Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 2: Global Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 3: PESTLE Analysis: Global Drugs for Urinary Incontinence and Overactive Bladder Market, 2017
Figure 4: Global Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 5: Global Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Generic and Branded, 2017
Figure 6: Global Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 7: Global Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 8: Global Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Region, 2017
Figure 9: Global Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Region, 2013-2022
Figure 10: Global Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Region, 2017
Figure 11: Global Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Country, 2017
Figure 12: Global Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Country, 2013-2022
Figure 13: Global Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Country, 2017
Figure 14: Global Per Capita Average Drugs for Urinary Incontinence and Overactive Bladder Market Expenditure, 2013-2022
Figure 15: Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 16: Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 17: Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 18: Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 19: Chinese Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 20: Chinese Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 21: Chinese Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 22: Chinese Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 23: Indian Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 24: Indian Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 25: Indian Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 26: Indian Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 27: Japanese Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 28: Japanese Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 29: Japanese Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 30: Japanese Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 31: Australian Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 32: Australian Drugs for Urinary Incontinence and Overactive Bladder Market, 2017-2022
Figure 33: Australian Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 34: Australian Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 35: Western European Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 36: Western European Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 37: Western European Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 38: Western European Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 39: UK Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 40: UK Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 41: UK Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 42: UK Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 43: Germany Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 44: Germany Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 45: Germany Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 46: Germany Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 47: France Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 48: France Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 49: France Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 50: France Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 51: Italy Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 52: Italy Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 53: Italy Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 54: Italy Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 55: Spain Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 56: Spain Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 57: Spain Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 58: Spain Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 59: Eastern European Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 60: Eastern European Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 61: Eastern European Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 62: Eastern European Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 63: Russian Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 64: Russian Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 65: Russian Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 66: Russian Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 67: North American Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 68: North American Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 69: North American Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 70: North American Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 71: USA Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 72: USA Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 73: USA Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 74: USA Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 75: South American Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 76: South American Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 77: South American Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 78: South American Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 79: Brazil Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 80: Brazil Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 81: Brazil Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 82: Brazil Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 83: Middle East Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 84: Middle East Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 85: Middle East Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 86: Middle East Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 87: African Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 88: African Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 89: African Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 90: African Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 91: Global Market Shares for Key Competitors of Drugs for Urinary Incontinence and Overactive Bladder Market, 2017
Figure 92: Allergan PLC: Financial Performance, 2013-2017
Figure 93: Astellas Pharma Inc: Financial Performance, 2013-2016
Figure 94: Merck & Company, Inc.: Financial Performance, 2013-2016
Figure 95: Mylan N.V.: Financial Performance, 2013-2017
Figure 96: Pfizer Inc.: Financial Performance, 2013-2017
Summary Figure: Global Drugs for Urinary Incontinence and Overactive Bladder Market, 2017-2022
Figure 1: Global Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 2: Global Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 3: PESTLE Analysis: Global Drugs for Urinary Incontinence and Overactive Bladder Market, 2017
Figure 4: Global Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 5: Global Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Generic and Branded, 2017
Figure 6: Global Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 7: Global Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 8: Global Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Region, 2017
Figure 9: Global Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Region, 2013-2022
Figure 10: Global Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Region, 2017
Figure 11: Global Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Country, 2017
Figure 12: Global Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Country, 2013-2022
Figure 13: Global Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Country, 2017
Figure 14: Global Per Capita Average Drugs for Urinary Incontinence and Overactive Bladder Market Expenditure, 2013-2022
Figure 15: Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 16: Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 17: Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 18: Asia-Pacific Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 19: Chinese Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 20: Chinese Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 21: Chinese Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 22: Chinese Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 23: Indian Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 24: Indian Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 25: Indian Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 26: Indian Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 27: Japanese Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 28: Japanese Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 29: Japanese Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 30: Japanese Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 31: Australian Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 32: Australian Drugs for Urinary Incontinence and Overactive Bladder Market, 2017-2022
Figure 33: Australian Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 34: Australian Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 35: Western European Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 36: Western European Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 37: Western European Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 38: Western European Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 39: UK Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 40: UK Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 41: UK Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 42: UK Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 43: Germany Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 44: Germany Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 45: Germany Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 46: Germany Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 47: France Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 48: France Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 49: France Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 50: France Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 51: Italy Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 52: Italy Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 53: Italy Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 54: Italy Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 55: Spain Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 56: Spain Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 57: Spain Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 58: Spain Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 59: Eastern European Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 60: Eastern European Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 61: Eastern European Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 62: Eastern European Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 63: Russian Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 64: Russian Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 65: Russian Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 66: Russian Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 67: North American Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 68: North American Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 69: North American Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 70: North American Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 71: USA Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 72: USA Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 73: USA Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 74: USA Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 75: South American Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 76: South American Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 77: South American Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 78: South American Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 79: Brazil Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 80: Brazil Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 81: Brazil Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 82: Brazil Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 83: Middle East Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 84: Middle East Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 85: Middle East Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 86: Middle East Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 87: African Drugs for Urinary Incontinence and Overactive Bladder Historic Market, 2013-2017
Figure 88: African Drugs for Urinary Incontinence and Overactive Bladder Forecast Market, 2017-2022
Figure 89: African Drugs for Urinary Incontinence and Overactive Bladder Market Share, by Segment, 2017
Figure 90: African Drugs for Urinary Incontinence and Overactive Bladder Market, Historic and Forecast Growth Rate, by Segment, 2013-2022
Figure 91: Global Market Shares for Key Competitors of Drugs for Urinary Incontinence and Overactive Bladder Market, 2017
Figure 92: Allergan PLC: Financial Performance, 2013-2017
Figure 93: Astellas Pharma Inc: Financial Performance, 2013-2016
Figure 94: Merck & Company, Inc.: Financial Performance, 2013-2016
Figure 95: Mylan N.V.: Financial Performance, 2013-2017
Figure 96: Pfizer Inc.: Financial Performance, 2013-2017
